These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. State of the art: radiolabeled microspheres treatment for liver malignancies. Deleporte A; Flamen P; Hendlisz A Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269 [TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres. Evans KA; Richardson MG; Pavlakis N; Morris DL; Liauw W; Bester L J Vasc Interv Radiol; 2010 Oct; 21(10):1521-6. PubMed ID: 20813542 [TBL] [Abstract][Full Text] [Related]
5. Radioembolization with 90Y microspheres: technical considerations. Salem R J Vasc Interv Radiol; 2007 Nov; 18(11):1460-1. PubMed ID: 18004003 [No Abstract] [Full Text] [Related]
6. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432. Ho S; Lau WY; Leung WT Chin Med J (Engl); 2001 Apr; 114(4):433-4. PubMed ID: 11780473 [No Abstract] [Full Text] [Related]
7. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases. Cao CQ; Yan TD; Bester L; Liauw W; Morris DL Br J Surg; 2010 Apr; 97(4):537-43. PubMed ID: 20205229 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of radioembolization in identifying patients with favorable tumor biology before living donor liver transplantation. Yu YD; Kim DS; Jung SW; Kim Y; Suh SO Transplantation; 2014 Sep; 98(5):e47-50. PubMed ID: 25171535 [No Abstract] [Full Text] [Related]
9. Yttrium-90 resin microsphere radioembolization using an antireflux catheter: an alternative to traditional coil embolization for nontarget protection. Morshedi MM; Bauman M; Rose SC; Kikolski SG Cardiovasc Intervent Radiol; 2015 Apr; 38(2):381-8. PubMed ID: 24989143 [TBL] [Abstract][Full Text] [Related]
10. Yttrium-90 radioembolization is a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases: further evidence in support of a new treatment paradigm. Hickey R; Lewandowski R; Salem R Ann Surg Oncol; 2015 Mar; 22(3):706-7. PubMed ID: 25358665 [No Abstract] [Full Text] [Related]
12. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. Salem R; Thurston KG J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462 [TBL] [Abstract][Full Text] [Related]
13. The role of radioembolization in colorectal cancer treatment. Kennedy AS Expert Rev Anticancer Ther; 2016; 16(4):375-6. PubMed ID: 26938710 [No Abstract] [Full Text] [Related]
14. Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors. Gates VL; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Nemcek AA; Omary R; Salem R Future Oncol; 2007 Feb; 3(1):73-81. PubMed ID: 17280504 [TBL] [Abstract][Full Text] [Related]
15. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. Salem R; Thurston KG J Vasc Interv Radiol; 2006 Oct; 17(10):1571-93. PubMed ID: 17056999 [TBL] [Abstract][Full Text] [Related]